Guthrie Medical Center

Sayre, Pennsylvania 18840

0 studies enrolling now · 3 studies all time

What they study most

Cancer, Contrast Induced Nephropathy, Lymphoma

Studies at this site

• Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients — Status unconfirmed
• Remote Electronic Patient Monitoring in Oncology Patients — Status unconfirmed
• Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia — Completed